Kedrion Biopharma
Evan Selig is an accomplished legal professional currently serving as Global General Counsel at Kedrion Biopharma since December 2022, where leadership is provided to a team of legal and compliance professionals in Italy and the United States. Prior roles include General Counsel and Chief Compliance Officer at Bio Products Laboratory Limited and various positions at ViiV Healthcare, including Assistant General Counsel with responsibilities covering Legal R&D, Global Communications, International Commercial Strategy, and European and North American legal matters. Earlier experience includes senior counsel roles at GSK and an associate position at Reed Smith, as well as serving as a Judicial Law Clerk in the Circuit Court of Montgomery County, Maryland. Evan Selig holds a J.D. from The George Washington University Law School and a B.A. in Economics from Colgate University.
This person is not in any teams
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.